可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Peuhkurinen K, Niemela M, Ylitalo A, et al. Effectiveness of amiodarone as a single oral dose for recentonset atrial fibrillation[J]. Am J Cardiol,2000,85(4):462-465.
[2] 赵水平,胡大一. 心血管病诊疗指南精读[M].北京:人民卫生出版社,2004:218.
[3] Shi Y, Li D , Tardif JC,et al. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure[J]. Cardiovasc Res,2002,54(2):456-461.
[4] Nakashima H,Kumagai K, Urata H,et al. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation[J]. Circulation,2000,101(22):2612-2617.
[5] 王学东,贾三庆,胡大一,等. 心房颤动患者循环血浆肾素、血管紧张素II和醛固酮的变化及临床意义[J]. 中国心血管杂志,2004,9(5):339-341.
[6] Goette A, Staack T, Rocken C, et al. Increased expression of extracellularsignal regulated kinase and angiotensinconverting enzyme in human atria during atrial fibrillation[J]. J Am Coll Cardiol, 2000,35(6):1669-1677.
[7] Li D, Shinagawa K, Pang L,et al. Effects of angiotensinconverting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacinginduced congestive heart failure[J].Circulation,2001, 104(21) : 2608-2614.
[8] Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin IImediated cardiovascular and renal diseases[J]. Pharmacol Rev, 2000,52(1):11-34.